Generalizability of Cardiovascular Safety Trials on SGLT2 Inhibitors to the Real World: Implications for Clinical Practice.

Nicolucci, Antonio

Generalizability of Cardiovascular Safety Trials on SGLT2 Inhibitors to the Real World: Implications for Clinical Practice. [electronic resource] - Advances in therapy 10 2019 - 2895-2909 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1865-8652

10.1007/s12325-019-01043-z doi


Aged
Aged, 80 and over
Benzhydryl Compounds--adverse effects
Canagliflozin--adverse effects
Cardiovascular Diseases--chemically induced
Cross-Sectional Studies
Diabetes Mellitus, Type 2--drug therapy
Female
Glucosides--adverse effects
Humans
Hypoglycemic Agents--adverse effects
Male
Middle Aged
Sodium-Glucose Transporter 2--drug effects
Sodium-Glucose Transporter 2 Inhibitors--adverse effects
United States